All Industries

Top healthtech Companies

659 healthtech companies, sorted by total funding raised.

Oscar HealthIPO

Health insurance company using technology to make health care simple, affordable, and accessible.

New York, United States1001–5000Healthcare, Insurance
Series F·$1.9B·Jun 2020
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth Equity·$1.5B·Apr 2025
LifeStance HealthIPO

Outpatient mental health provider offering in-person and virtual therapy, psychiatry, and psychol...

Scottsdale, United States5001–10000healthtech, Healthcare
Private Equity·$1.4B·Apr 2020
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Life Sciences
Series D·$1.4B·Jun 2020
BrightSpring Health ServicesIPO

Leading provider of diversified home and community-based health and pharmacy services to medicall...

Louisville, United States10001+healthtech, Healthcare
Private Equity·$1.3B·Mar 2019
Denali TherapeuticsIPO

Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...

South San Francisco, United States201–500Biotech, healthtech
Venture Unknown·$1.3B·Dec 2025
BridgeBio PharmaIPO

BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...

Palo Alto, United States501–1000healthtech, biotech
Growth Equity·$1.2B·Jan 2024
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Drug Discovery
Series D·$1.1B·Feb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
Ocular TherapeutixIPO

Biopharmaceutical company developing sustained-release hydrogel therapies targeting retinal disea...

Bedford, United States201–500healthtech, Biotech
Private Equity·$836.7M·Sep 2025
Ginkgo BioworksIPO

Our mission is to make biology easier to engineer.

Boston, United States501–1000Automation, Diagnostics
Extension Round·$790.0M·May 2020
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Life Sciences
Venture Unknown·$722.0M·Jul 2025
Generate BiomedicinesIPO

AI-powered generative biology platform creating novel protein therapeutics across antibodies, pep...

Cambridge, United States201–500Artificial Intelligence, Biotech
Corporate Round·$693.0M·Dec 2024
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series B·$612.0M·Oct 2022
Century TherapeuticsIPO

Century Therapeutics develops allogeneic iPSC-derived NK and T cell therapies for cancer and auto...

Philadelphia, United States51–200healthtech, Biotech
Corporate Round·$605.0M·Jan 2026
Edgewise TherapeuticsIPO

Clinical-stage biopharmaceutical company developing oral therapies for serious skeletal and cardi...

Boulder, United States51–200Biotech, Therapeutics
Growth Equity·$585.0M·Apr 2025
ImmunovantIPO

Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...

New York, United States51–200healthtech, biotech
Angel·$585.0M·Oct 2019
CelcuityIPO

Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...

Minneapolis, United States51–200Biotech, Diagnostics
Convertible·$550.1M·Aug 2025
Warby ParkerIPO

Warby Parker offers affordable eyewear and a try-at-home service.

New York, United States1001–5000E-Commerce, Retail
Series G Plus·$549.5M·Dec 2020
Guardant HealthIPO

Guardant Health is an oncology company.

Palo Alto, United States1001–5000Biotech, Healthcare
Series E·$540.0M·May 2017
Beam TherapeuticsIPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United States201–500Biotech, Gene Editing
Growth Equity·$528.0M·Feb 2026
Relay TherapeuticsIPO

Clinical-stage precision medicines company using protein-motion-driven drug discovery to design s...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$520.0M·Dec 2018
ADC Therapeutics SA Common SharesIPO

Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.

Lausanne, Switzerland201–500healthtech, biotech
Series E·$501.0M·Jun 2019
Biohaven Ltd. Common SharesIPO

Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...

New Haven, United States201–500healthtech, biotech
Venture Unknown·$493.6M·Aug 2020
ICONIPO

3-D printed homes.

Austin, United States201–500Construction Tech, 3D Printing
Series C·$485.0M·Feb 2025